A Novel Anti-Thrombotic, Glenzocimab, in Covid-19 acute respiratory distress syndrome (Cov-ARDS).
J. Pottecher (Strasbourg, France), V. Sato (Sau Paulo, Brazil), Y. Plétan (Paris, France), A. Comenducci (Paris, France), V. Desort-Henin (paris, France), M. Jandrot-Perrus (Paris, France), S. Binay (Paris, France), A. Meilhoc (Paris, France), G. Avenard (Paris, France)
Source: International Congress 2022 – COVID-19 acute respiratory distress syndrome and beyond
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Pottecher (Strasbourg, France), V. Sato (Sau Paulo, Brazil), Y. Plétan (Paris, France), A. Comenducci (Paris, France), V. Desort-Henin (paris, France), M. Jandrot-Perrus (Paris, France), S. Binay (Paris, France), A. Meilhoc (Paris, France), G. Avenard (Paris, France). A Novel Anti-Thrombotic, Glenzocimab, in Covid-19 acute respiratory distress syndrome (Cov-ARDS).. 2310
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|